High intensity continuous renal replacement therapy does not improve mortality in critically ill patients

Research output: Contribution to journalComment / DebateOtherpeer-review

Abstract

In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.

Original languageEnglish
Pages (from-to)52-53
Number of pages2
JournalJournal of the Intensive Care Society
Volume11
Issue number1
Publication statusPublished - 1 Jan 2010
Externally publishedYes

Cite this

@article{dacc76a2c6b24e8fbc8504c47a283370,
title = "High intensity continuous renal replacement therapy does not improve mortality in critically ill patients",
abstract = "In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.",
author = "R. Bellomo",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "52--53",
journal = "Intensive Care Society. Journal",
issn = "1751-1437",
publisher = "SAGE Publications Ltd",
number = "1",

}

High intensity continuous renal replacement therapy does not improve mortality in critically ill patients. / Bellomo, R.

In: Journal of the Intensive Care Society, Vol. 11, No. 1, 01.01.2010, p. 52-53.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - High intensity continuous renal replacement therapy does not improve mortality in critically ill patients

AU - Bellomo, R.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.

AB - In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.

UR - http://www.scopus.com/inward/record.url?scp=77952766680&partnerID=8YFLogxK

M3 - Comment / Debate

AN - SCOPUS:77952766680

VL - 11

SP - 52

EP - 53

JO - Intensive Care Society. Journal

JF - Intensive Care Society. Journal

SN - 1751-1437

IS - 1

ER -